Publications
Journal Article (86)
1.
Journal Article
1869 (8), 166835 (2023)
Glycation modulates superoxide dismutase 1 aggregation and toxicity in models of sporadic amyotrophic lateral sclerosis. Biochimica et Biophysica Acta-Molecular Basis of Disease 2.
Journal Article
146, pp. 369 - 385 (2023)
More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy. Acta Neuropathologica 3.
Journal Article
166 (5), pp. 862 - 874 (2023)
Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's disease. Journal of Neurochemistry 4.
Journal Article
38 (9), pp. 1585 - 1597 (2023)
Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta-Analysis. Movement Disorders 5.
Journal Article
24 (17), 13435 (2023)
Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease. International Journal of Molecular Sciences 6.
Journal Article
29 (1), 111 (2023)
The alpha-synuclein oligomers activate nuclear factor of activated T-cell (NFAT) modulating synaptic homeostasis and apoptosis. Molecular Medicine 7.
Journal Article
39 (4-6), pp. 321 - 335 (2023)
Uncovering the Molecular Link Between Lead Toxicity and Parkinson's Disease. Antioxidants & redox signaling 8.
Journal Article
19 (8), pp. 453 - 454 (2023)
AI and protein structure and function in neurological disease: relevance to disease management. Nature Reviews Neurology 9.
Journal Article
38 (7), pp. 1127 - 1142 (2023)
Defining the riddle in order to solve it: There is more than one "Parkinson's Disease". Movement Disorders 10.
Journal Article
Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease. Journal of Neurochemistry, in press (2023)
11.
Journal Article
123 (14), pp. 9094 - 9138 (2023)
Targeting Biomolecular Condensation and Protein Aggregation against Cancer. Chemical Reviews 12.
Journal Article
13 (4), pp. 633 - 636 (2023)
People with early onset Parkinson’s disease: empowered to improve care. Journal of Parkinson's Disease: JPD 13.
Journal Article
29 (33), e202300649 (2023)
Chemical Synthesis of Alpha-Synuclein Proteins via Solid-Phase Peptide Synthesis and Native Chemical Ligation. Chemistry – A European Journal 14.
Journal Article
14, 1918 (2023)
Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storage. Nature Communications 15.
Journal Article
13 (2), pp. 179 - 196 (2023)
miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy. Journal of Parkinson's Disease: JPD 16.
Journal Article
23, 174 (2023)
Glycosylation spectral signatures for glioma grade discrimination using Raman spectroscopy. BMC Cancer 17.
Journal Article
177, 105995 (2023)
The immune system in Parkinson's disease: From biology to diagnosis and therapeutic targets. Neurobiology of Disease 18.
Journal Article
11 (8), 2209 (2023)
Genome-Wide Expression Profile in People with Optic Neuritis Associated with Multiple Sclerosis. Biomedicines 19.
Journal Article
11 (2), 505 (2023)
Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials. Biomedicines 20.
Journal Article
38 (2), pp. 162 - 177 (2022)
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts. Movement Disorders 21.
Journal Article
12, pp. 2397 - 2422 (2022)
Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity. Journal of Parkinson's Disease: JPD 22.
Journal Article
11 (22), 3673 (2022)
Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation. Cells 23.
Journal Article
269, 104721 (2022)
Ectosomes and exosomes modulate neuronal spontaneous activity. Journal of Proteomics 24.
Journal Article
Hexokinase 2: The preferential target of trehalose-6-phosphate over hexokinase 1. Journal of Cellular Biochemistry (2022)
25.
Journal Article
10 (1), 98 (2022)
Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathologica Communications 26.
Journal Article
168, 105696 (2022)
Extracellular alpha-synuclein: Sensors, receptors, and responses. Neurobiology of Disease 27.
Journal Article
7, 65 (2021)
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease. NPJ Parkinsons Disease 28.
Journal Article
Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2020)
29.
Journal Article
404, pp. 58 - 71 (2020)
Tapentadol Prevent Motor Impairments in a Mouse Model of Dyskinesia. Neuroscience 30.
Journal Article
116 (51), pp. 25991 - 2600 (2019)
Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proceedings of the National Academy of Sciences of the United States of America 31.
Journal Article
28, pp. 65 - 77 (2019)
Cytosolic trapping of a mitochondrial heat shock protein is an early pathological event in synucleinopathies. Cell Reports 32.
Journal Article
47, pp. 909 - 918 (2019)
Investigating targets for neuropharmacological intervention by molecular dynamics simulations. Biochemical Society Transactions 33.
Journal Article
8, 18 (2019)
Dihydromyricetin and salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy. Translational neurodegeneration 34.
Journal Article
47 (3), pp. 827 - 838 (2019)
LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders? Biochemical Society Transactions 35.
Journal Article
85 (5), pp. 691 - 703 (2019)
Seeding variability of different alpha synuclein strains in synucleinopathies. Annals of Neurology 36.
Journal Article
12, 107 (2019)
Spreading of α-synuclein and tau: a systematic comparison of the mechanisms involved. Frontiers in Molecular Neuroscience 37.
Journal Article
22, 101135 (2019)
Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity. Redox Biology 38.
Journal Article
47, pp. 197 - 207 (2019)
The role of LRRK2 in cell signalling. Biochemical Society Transactions 39.
Journal Article
33 (2), pp. 2116 - 2131 (2019)
Monitoring α-synuclein multimerization in vivo. The FASEB Journal 40.
Journal Article
14, 5 (2019)
Dementia with Lewy bodies: an update and outlook. Molecular neurodegeneration 41.
Journal Article
27 (1), pp. 79 - 91 (2019)
Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding. Bioorganic & Medicinal Chemistry 42.
Journal Article
28 (1), pp. 31 - 50 (2019)
Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein. Human Molecular Genetics 43.
Journal Article
18 (8), foy108 (2018)
Identification of novel protein phosphatases as modifiers of alpha-synuclein aggregation in yeast. FEMS Yeast Research 44.
Journal Article
33 (11), pp. 1675 - 1684 (2018)
Sensing α-Synuclein from the outside via the prion problem: implications for neurodegeneration. Movement Disorders 45.
Journal Article
55, pp. 8754 - 8763 (2018)
Diabetes mellitus as a risk factor for Parkinson's disease: a molecular point of view. Molecular Neurobiology 46.
Journal Article
38, pp. 1539 - 1550 (2018)
Secretion and uptake of α-synuclein via extracellular vesicles in cultured cells. Cellular and Molecular Neurobiology 47.
Journal Article
18 (6), foy066 (2018)
The trehalose protective mechanism during thermal stress in Saccharomyces cerevisiae: the roles of Ath1 and Agt1. FEMS Yeast Research 48.
Journal Article
6, 79 (2018)
Membrane binding, internalization, and sorting of alpha-synuclein in the cell. Acta Neuropathologica Communications 49.
Journal Article
Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors. Molecular Psychiatry, 10.1038/s41380-018-0110-9 (2018)
50.
Journal Article
8, 6965 (2018)
(Poly)phenol-digested metabolites modulate alpha-synuclein toxicity by regulating proteostasis. Scientific Reports